News
Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
"It's criminal to put someone on a GLP-1 and not put them on a dietary plan," says Phil Vella, founder of Vita Bella Health, ...
Josephs joins forces with LifeRx.md to redefine health through doctor-led GLP‑1 wellness programs—merging celeb credibility ...
2d
MedPage Today on MSNMost on Wegovy a Year Later; Food Label Weight Stigma; Make Your Own GLP-1 Drugs?GOP leaders are racing to try to get the bill to the White House by July 4. The multi-trillion-dollar bill would unlock tax ...
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...
Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
13h
Live Science on MSNOzempic-style drugs treat type 1 diabetes, not only type 2, study findsA clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
There are two ways in which industry can respond to the GLP-1 craze. On the one hand, they can, like Nestlé, create smaller ...
GLP-1 drugs, which have seen widespread success, have been linked to a number of cases of pancreatitis in the UK, which have ...
FOX News on MSN12h
New weight loss medicine seen as an alternative to Ozempic, GLP-1 drugsOne of the largest theater chains in the US again files for bankruptcy Officials provide update on California fireworks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results